Bill of Health
OCTOBER 26, 2023
By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the World Health Organization officially declared the “emergency” phase of the COVID-19 pandemic over. This pattern has had lethal consequences during the COVID-19 pandemic, harming efforts to advance global solidarity.
Bill of Health
DECEMBER 12, 2023
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. Impact of the judgment: what have records disclosed shown?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
OCTOBER 25, 2022
– Samsung reduces the time required to label lung X-Rays used to diagnose COVID-19 by 84% by using AI to identify and then label the most informative images first. In addition to these challenges specific to their industry, pharma companies are all also presented with classic barriers to implementation.
HIT Consultant
APRIL 7, 2023
The research report on the drug discovery outsourcing market states that the pharmaceutical industry is expanding thoroughly with new extensions and high-end research programs. Moreover, the government projects and the bilateral relationship are also anticipated to increase drug production.
Health Populi
JULY 1, 2020
health systems are projected to lose $323 billion in 2020 due to declining inpatient and outpatient volumes caused by the COVID-19 pandemic’s impact on the “normal” hospital business. Some hospitals in regions of these states are approaching full capacity in ICUs and COVID units. fall in outpatient volume.
Bill of Health
AUGUST 29, 2022
On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. government funding, announced that it felt “a special obligation … to use our resources to bring this pandemic to an end as quickly as possible.” Pandemic Pledges. Moderna’s Pledge.
Bill of Health
SEPTEMBER 28, 2023
By Nikhil Chaudhry and Reshma Ramachandran Earlier this month, the Department of Health and Human Services announced that it had successfully included a reasonable pricing provision in a $326M investment contract with Regeneron for development of a next generation monoclonal antibody therapy for COVID-19. pharmaceutical market.
Expert insights. Personalized for you.
299 
Let's personalize your content